封面
市場調查報告書
商品編碼
1561046

細胞培養基市場規模、佔有率、成長分析,按類型、按應用、按最終用戶、按地區 - 行業預測,2024-2031 年

Cell Culture Media Market Size, Share, Growth Analysis, By Type, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 213 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年細胞培養基的全球市場規模為52億美元,從2023年的62.3億美元成長到2031年的204.5億美元,在預測期間(2024-2031)預計複合年成長率為16.02% 。

由於新傳染病的增加,預計該市場將繼續成長。製藥和生物技術公司是細胞培養基的主要用戶,因為它們支持新型創新疫苗的開發。該技術解決了與動物測試相關的倫理問題,並為傳統的動物疫苗測試提供了可行的替代方案。細胞培養基消除了研究過程中動物犧牲的需要,提供了更人性化的解決方案。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 專利分析
  • 價值鏈分析
  • 供應鏈分析
  • 價格分析
  • 貿易分析
  • 監管環境
  • 客戶和購買標準分析

細胞培養基市場:依類型

  • 無血清培養基
    • CHO培養基
    • HEK 293 介質
    • BHK培養基
    • VERO細胞培養基
    • 無血清幹細胞培養基
    • 免疫細胞培養基
    • 昆蟲細胞培養基
    • 其他無血清培養基
  • 常規介質和鹽
  • 幹細胞培養基
  • 化學成分確定的 (CD) 介質
  • 專門的培養基
  • 其他細胞培養基

細胞培養基市場:依應用分類

  • 市場概況
  • 生物製藥製造
    • 單株抗體生產
    • 疫苗生產
    • 其他治療性蛋白質製造應用
  • 診斷
  • 組織工程與再生醫學
    • 細胞/基因治療
    • 其他組織工程及再生醫學應用
  • 藥物篩檢與開發
  • 其他用途

細胞培養基市場:依最終用戶分類

  • 市場概況
  • 製藥和生物技術公司
  • 醫院和診斷實驗室
  • 研究/學術機構
  • 其他最終用戶

細胞培養基市場規模:按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率(2023年)

主要企業簡介

  • Thermo Fischer Scientific
  • Merck KGAA
  • Danaher
  • Sartorius AG
  • Corning Incorporated
  • Fujifilm Holdings Corporation
  • Lonza
  • Becton, Dickinson And Company(BD)
  • Stemcell Technologies
  • Miltenyi Biotec
  • Himedia Laboratories
  • Biologos
  • Promocell Gmbh
  • Invivogen
  • Pan-Biotech
  • Cellular Technology Limited
  • Cyagen Biosciences
  • Biowest
  • Akron Biotech
  • Kcell Biosciences
簡介目錄
Product Code: SQMIG35H2057

Global Cell Culture Media Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.23 billion in 2023 to USD 20.45 billion by 2031, growing at a CAGR of 16.02% during the forecast period (2024-2031).

The market is projected to grow in the future due to the rise of new communicable diseases. Pharmaceutical and biotechnology companies are significant users of cell culture media, as it supports the development of new and innovative vaccines. This technology provides a viable alternative to traditional vaccine trials conducted on animals, addressing ethical concerns associated with animal testing. Cell culture media offers a more humane solution by eliminating the need for animal sacrifice in the research process.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Media Market Segmental Analysis

Global Cell Culture Media Market is segmented by Type, Application, End User and Region. Based on Type , the market is segmented into Serum-Free Media (CHO Media, HEK 293 Media, BHK Media, VERO Cell Media, Serum-Free Stem Cell Media, Immune Cell Media, Insect Cell Media, Other Serum-Free Media), Classical Media & Salts, Stem Cell Culture Media, Chemically Defined (CD) Media, Specialty Media, Other Cell Culture Media. Based on Application, the market is segmented into Biopharmaceutical Production (Monoclonal Antibody Production, Vaccine Production, Other Therapeutic Protein Production Applications), Diagnostics, Tissue Engineering & Regenerative Medicine (Cell & Gene Therapy, Other Tissue Engineering & Regenerative Medicine Applications), Drug Screening & Development, Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Cell Culture Media Market

The recent pandemic has accelerated market growth significantly. Cell culture media have become crucial for producing and testing new vaccines and medicines. Over the past few years, the expansion of biotechnology and pharmaceutical companies has driven increased demand for cell culture media, which are essential for developing innovative vaccines and medicines. The rise in stringent safety regulations for vaccines and efforts to curb the spread of communicable diseases have led researchers to increasingly rely on cell culture media for testing and trials.

Restraints in the Global Cell Culture Media Market

Cell culture media predominantly uses plastic materials, which accumulate over time and contribute to significant waste. Plastics are not easily degradable and, when incinerated, release harmful gases. Many countries are imposing bans on plastics due to their environmental impact. Since these plastics are intended for single use only, they cannot be reused or recycled. The rising regulatory standards for cell culture media are further driving up product costs at an accelerated pace.

Market Trends of the Global Cell Culture Media Market

Regenerative medicine represents an innovative and rapidly growing field focused on developing therapies to replace or repair damaged tissues and organ systems within the human body. This field leverages a combination of cells, biomaterials, and molecules to restore bodily structures affected by injury or disease. As these therapies depend on specialized cell culture media to support their development and application, the increasing demand for regenerative medicine is anticipated to significantly drive the growth of the cell culture media market.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Patent Analysis
  • Value Chain Analysis
  • Supply Chain Analysis
  • Pricing Analysis
  • Trade Analysis
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis

Cell Culture Media Market, By Type

  • Serum-Free Media
    • CHO Media
    • HEK 293 Media
    • BHK Media
    • VERO Cell Media
    • Serum-Free Stem Cell Media
    • Immune Cell Media
    • Insect Cell Media
    • Other Serum-Free Media
  • Classical Media & Salts
  • Stem Cell Culture Media
  • Chemically Defined (CD) Media
  • Specialty Media
  • Other Cell Culture Media

Cell Culture Media Market, By Application

  • Market Overview
  • Biopharmaceutical Production
    • Monoclonal Antibody Production
    • Vaccine Production
    • Other Therapeutic Protein Production Applications
  • Diagnostics
  • Tissue Engineering & Regenerative Medicine
    • Cell & Gene Therapy
    • Other Tissue Engineering & Regenerative Medicine Applications
  • Drug Screening & Development
  • Other Applications

Cell Culture Media Market, By End User

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Other End Users

Cell Culture Media Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Thermo Fischer Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGAA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson And Company (BD)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stemcell Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Himedia Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biologos
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promocell Gmbh
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invivogen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pan-Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cellular Technology Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cyagen Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biowest
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Akron Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kcell Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments